Comvita Ltd
NZX:CVT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Comvita Ltd
NZX:CVT
|
NZ |
|
Asia Allied Infrastructure Holdings Ltd
HKEX:711
|
HK |
|
Shree Cement Ltd
NSE:SHREECEM
|
IN |
|
Godrej Properties Ltd
NSE:GODREJPROP
|
IN |
|
D
|
Danen Technology Corp
TWSE:3686
|
TW |
|
B
|
Bristol-Myers Squibb Co
XETRA:BRM
|
US |
|
O
|
Octodec Investments Ltd
JSE:OCT
|
ZA |
|
S
|
Square Enix Holdings Co Ltd
TSE:9684
|
JP |
|
J
|
Jushi Holdings Inc
CNSX:JUSH
|
US |
|
Hyzon Motors Inc
NASDAQ:HYZN
|
US |
|
I
|
InfuSystem Holdings Inc
AMEX:INFU
|
US |
|
H
|
Hargreaves Services PLC
XBER:H6W
|
UK |
|
Danone SA
OTC:GPDNF
|
FR |
|
Genesis Healthcare Inc
OTC:GENN
|
US |
|
Garb Oil & Power Corp
OTC:GARB
|
US |
Comvita Ltd
Comvita Ltd. engages in the manufacture and marketing of healthcare, personal care, and functional food products. The company is headquartered in Te Puke, Bay Of Plenty. The company went IPO on 2003-11-14. The firm is engaged in the manufacturing and marketing natural health products, and apiary ownership and management. Its segments include New Zealand, which includes production and extraction facilities at Paengaroa, Northland, Waikato, Whanganui, Wairarapa, Hawkes Bay, East Coast, Nelson and Timaru, and Apiary operations in Northland, Waikato, Whanganui, Wairarapa, Hawkes Bay and East Coast; Australia, which includes over 242 hectares of olive leaf plantation, extraction and manufacturing facility in rural Queensland; Asia, which includes operations in Hong Kong, Taiwan, China, Japan, Korea and South Korea; Europe, which includes the operations in the United Kingdom and European markets; Medical, which includes bulk medical honey sales and royalty payments received from Derma Sciences, Inc., and Other, which captures revenue earned from other areas, including bulk sales, the United States and Canada.
Comvita Ltd. engages in the manufacture and marketing of healthcare, personal care, and functional food products. The company is headquartered in Te Puke, Bay Of Plenty. The company went IPO on 2003-11-14. The firm is engaged in the manufacturing and marketing natural health products, and apiary ownership and management. Its segments include New Zealand, which includes production and extraction facilities at Paengaroa, Northland, Waikato, Whanganui, Wairarapa, Hawkes Bay, East Coast, Nelson and Timaru, and Apiary operations in Northland, Waikato, Whanganui, Wairarapa, Hawkes Bay and East Coast; Australia, which includes over 242 hectares of olive leaf plantation, extraction and manufacturing facility in rural Queensland; Asia, which includes operations in Hong Kong, Taiwan, China, Japan, Korea and South Korea; Europe, which includes the operations in the United Kingdom and European markets; Medical, which includes bulk medical honey sales and royalty payments received from Derma Sciences, Inc., and Other, which captures revenue earned from other areas, including bulk sales, the United States and Canada.
